2018 Onco-Nephrology Symposium

2018 Onco-Nephrology Symposium is organized by The University of Texas MD Anderson Cancer Center and will be held on Dec 07, 2018 at MD Anderson Cancer Prevention Center, Houston, Texas, United States of America. 

The target audience for this medical event is nephrologists, oncologists, advanced practice providers, and nurse practitioners. This CME Conference has been approved for a maximum of 7.25 AMA PRA Category 1 Credits.

Accreditation/Credit Designation Information:
Physicians:
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™.
The session entitled, Ethics: Dialysis, A Palliative Perspective, has been designated by The University of Texas MD Anderson Cancer Center for .50 AMA PRA Category 1 Credits™ in medical ethics and/or professional responsibility.

MOC Points:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity.

In order to receive MOC points, you must pass the post-test with a score of 70% or higher.

Description:
Kidney disease is common in patients with cancer. As cancer treatments advance in efficacy and scope, their effects on the kidney and bodily homeostasis become increasingly complex to diagnose and manage. There exists a very real need for nephrologists and trainees to develop proficiency in the recognition and therapy of the unique renal syndromes that arise in the setting of cancer.

The goal of this symposium is to inform physicians and advanced practice providers about the current best practices, in the hopes of improving their approach to the diagnosis and treatment of cancer-associated kidney disorders.

By presenting a spectrum of evidence-based recommendations, we endeavor to effect a positive change. We anticipate that participants will be able to apply these lessons to refine their practices and, hopefully, improve patient outcomes.

Educational Objectives:
After attending the symposium, participants should be able to:
• Diagnose the common renal complications arising from cancer and its treatments (Knowledge, Competence);
• Prevent or treat nephrotoxicity associated with cancer (Knowledge, Competence, Performance); 
• Recognize and treat electrolyte disorders in patients with cancer (Knowledge, Competence, Performance);
• Learn about the role of a nephrologist in kidney cancer (Knowledge); 
• Implement strategies for discussing dialysis at the end-of-life care (Knowledge, Competence, Performance, Patient Outcomes).

Educational Methods:
• Lecture/Didactic
• Case Study
• Questions and Answer Sessions
• Poster Sessions